Xeris Biopharma Holdings, Inc.

Nasdaq:XERS

Pharmaceutical Preparations·CHICAGO, IL

Xeris is a genus of horntails found in North America and Eurasia. Achille Costa circumscribed the genus in 1894.

Financials

18 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/2/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/6/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
3/2/26	Q1 FY2026	→
1/8/26	Q4 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/6/25	Q1 FY2025	→
↓

News (8-K)

23 shown

Filed	Type	Description
2/27/26	Reg FD	Regulation FD Disclosure	→
12/1/25	Reg FD	Regulation FD Disclosure	→
6/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/3/25	Reg FD	Regulation FD Disclosure	→
3/28/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

18 shown

Filed	Form	Description
3/2/26	S-8	S-8	→
4/23/25	ARS	ARS	→
3/6/25	S-8	S-8	→
3/6/25	S-3	S-3	→
8/8/24	S-8	S-8	→
4/23/24	ARS	ARS	→
↓

Filing History(278 filings)

TypeDateAccessionPeriodSize

Mar 5, 2026

0001875714-26-000004FORM 4

Mar 5, 2026

10.6 KB

Mar 4, 2026

0001652410-26-000006FORM 4

Mar 2, 2026

6.4 KB

144

Mar 2, 2026

0001950047-26-002003

—

6.2 KB

S-8

Mar 2, 2026

0001867096-26-000017S-8

—

79.5 KB

10-K

Mar 2, 2026

0001867096-26-00001610-K

Dec 31, 2025

29.6 MB

8-K

Mar 2, 2026

0001867096-26-0000128-K

Mar 2, 2026

317.0 KB

8-K

Feb 27, 2026

0001867096-26-0000108-K

Feb 26, 2026

217.9 KB

Feb 25, 2026

0002058704-26-000004FORM 4

Feb 24, 2026

6.5 KB

Feb 2, 2026

0001553595-26-000004FORM 4

Jan 30, 2026

11.5 KB

Feb 2, 2026

0002031695-26-000004FORM 4

Jan 30, 2026

12.6 KB

Feb 2, 2026

0001875714-26-000002FORM 4

Jan 30, 2026

11.5 KB

Feb 2, 2026

0002058704-26-000002FORM 4

Jan 30, 2026

9.1 KB

Feb 2, 2026

0001652410-26-000004FORM 4

Jan 30, 2026

13.4 KB

SCHEDULE 13G/A

Jan 30, 2026

0000102909-26-000256

—

6.8 KB

Jan 9, 2026

0002031695-26-000002FORM 4

Jan 8, 2026

5.7 KB

144

Jan 8, 2026

0001950047-26-000273

—

4.8 KB

8-K

Jan 8, 2026

0001867096-26-0000048-K

Jan 8, 2026

217.2 KB

Jan 6, 2026

0001553595-26-000002FORM 4

Jan 5, 2026

16.3 KB

Jan 5, 2026

0001652410-26-000002FORM 4

Jan 2, 2026

5.3 KB

144

Dec 19, 2025

0001950047-25-010581

—

5.8 KB

Dec 19, 2025

0001410781-25-000006FORM 4

Dec 19, 2025

4.9 KB

Dec 15, 2025

0001635065-25-000004FORM 4

Dec 12, 2025

5.0 KB

144

Dec 12, 2025

0001950047-25-010215

—

4.6 KB

Dec 2, 2025

0001652410-25-000005FORM 4

Dec 1, 2025

5.1 KB

8-K

Dec 1, 2025

0001867096-25-0001618-K

Dec 1, 2025

168.0 KB

25 filings shown

Xeris Biopharma Holdings, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(278 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/23/25	DEFA14A	DEFA14A	→
4/23/25	DEF 14A	DEF 14A	→
4/23/24	DEFA14A	DEFA14A	→
4/23/24	DEF 14A	DEF 14A	→
4/26/23	DEFA14A	DEFA14A	→
4/26/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
3/5/26	4	4	→
3/4/26	4	4	→
2/25/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
↓

Filed	Form	Description
3/2/26	144	144	→
1/30/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/8/26	144	144	→
12/19/25	144	144	→
12/12/25	144	144	→
11/13/25	144	144	→
↓